il1rap

The Study Breaking Pancreatic Cancer's 'Shield' Was Co-Written by the Drug's Maker

The 'breakthrough' bought engineered mice eleven extra days, its headline human numbers come from a post-hoc subgroup, and one author is the chief scientist of the company that makes the drug.